Target intelligence / Profile preview

Type II 3-dehydroquinate dehydratase (Type II DHQD)

Target
Type II DHQD
Molecular classification
Enzyme, Lyase, Hydro-lyase
01

Overview

Type II 3-dehydroquinate dehydratase is an enzyme involved in the shikimate pathway, which is crucial in bacteria, fungi, and plants for the biosynthesis of aromatic amino acids and other aromatic compounds[1][2][4]. It catalyzes the dehydration of 3-dehydroquinate to 3-dehydroshikimate via an enolate intermediate, forming part of the third step in the shikimate pathway; this enzyme is structurally distinct from the type I form but accomplishes the same overall reaction. In type II DHQD, the gene is typically designated as aroQ, and the enzyme exists as a dodecamer with a flavodoxin fold, contrasting the (α/β)8 fold of type I DHQD[1]. Because the shikimate pathway is not found in mammals, type II DHQD is considered a highly attractive target for the development of new antimicrobials and herbicides[2][4], but no drugs targeting it are clinically approved at present.

Other names
Type II dehydroquinate dehydrataseType II DHQase3-dehydroquinate dehydratase IIaroQ gene product (for the gene encoding the enzyme)Dehydroquinase II3-dehydroquinase II
02

Mechanism of action

Competitive inhibition of the active site; Inhibition of enzyme function in the shikimate pathway, blocking synthesis of aromatic metabolites essential for microbes and plants

03

Biological functions

Biosynthesis of aromatic amino acids (phenylalanine, tyrosine, tryptophan)Third step of the shikimate pathway
04

Disease associations

Infection (target in microbial and parasite pathogens)Other (antimicrobial and herbicide development)
05

Safety considerations

Selectivity for microbial over mammalian systems is essential, since the pathway is absent in mammals
06

Interacting drugs

Experimental inhibitors targeting the shikimate pathway (no widely approved therapeutics currently; some inhibitors developed for research and herbicidal uses)
07

Biomarkers

None specific for clinical use; not used as a biomarker in human medicine

Beyond the preview

Go deeper on Type II 3-dehydroquinate dehydratase (Type II DHQD).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Type II 3-dehydroquinate dehydratase (Type II DHQD).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call